Literature DB >> 6412932

Thrombosis in systemic lupus erythematosus: striking association with the presence of circulating lupus anticoagulant.

M L Boey, C B Colaco, A E Gharavi, K B Elkon, S Loizou, G R Hughes.   

Abstract

The lupus anticoagulant was found in the plasma of 31 of 60 patients with systemic lupus erythematosus and other connective tissue disorders (mixed connective tissue disease, systemic vasculitis, polyarteritis nodosa, primary sicca syndrome, discoid lupus, Behcet's syndrome, and systemic sclerosis). Strong associations were found with biological false positive seroreaction for syphilis and thrombocytopenia. The most striking association, however, was with the high prevalence of thrombosis. This tendency to thrombosis was independent of disease activity of systemic lupus erythematosus. The lupus anticoagulant appears to be a useful marker for a subset of patients with systemic lupus erythematosus at risk for the development of thromboembolic complications.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6412932      PMCID: PMC1549560          DOI: 10.1136/bmj.287.6398.1021

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  19 in total

1.  The natural history of systemic lupus erythematosus: an approach to its study through chronic biologic false positive reactors.

Authors:  J E MOORE; W B LUTZ
Journal:  J Chronic Dis       Date:  1955-03

2.  The partial thromboplastin time with kaolin. A simple screening test for first stage plasma clotting factor deficiencies.

Authors:  R R PROCTOR; S I RAPAPORT
Journal:  Am J Clin Pathol       Date:  1961-09       Impact factor: 2.493

3.  Circulating anticoagulants: a study of 40 cases and a review of the literature.

Authors:  A MARGOLIUS; D P JACKSON; O D RATNOFF
Journal:  Medicine (Baltimore)       Date:  1961-05       Impact factor: 1.889

4.  Hypergammaglobulinemia, circulating anticoagulant, and biologic false positive Wassermann reaction; a study in two cases.

Authors:  A B LAURELL; I M NILSSON
Journal:  J Lab Clin Med       Date:  1957-05

5.  Purification and kinetic studies on a circulating anticoagulant in a suspected case of lupus erythematosus.

Authors:  E T Yin; L W Gaston
Journal:  Thromb Diath Haemorrh       Date:  1965-09-01

6.  A clinical study of the lupus anticoagulant.

Authors:  M A Schleider; R L Nachman; E A Jaffe; M Coleman
Journal:  Blood       Date:  1976-10       Impact factor: 22.113

7.  Studies on the Coagulation Defect in a Case of Thrombocytopenic Purpura Complicated by Thrombosis.

Authors:  P M Aggeler; S Lindsay; S P Lucia
Journal:  Am J Pathol       Date:  1946-11       Impact factor: 4.307

Review 8.  Circulating anticoagulants.

Authors:  D Green
Journal:  Med Clin North Am       Date:  1972-01       Impact factor: 5.456

9.  The occurrence of circulating anticoagulants in patients with syphilitic and biologically false positive antilipoidal antibodies.

Authors:  E A Johansson; A Lassus
Journal:  Ann Clin Res       Date:  1974-04

10.  Arterial thrombosis, intrauterine death and "lupus" antiocoagulant: detection of immunoglobulin interfering with prostacyclin formation.

Authors:  L O Carreras; G Defreyn; S J Machin; J Vermylen; R Deman; B Spitz; A Van Assche
Journal:  Lancet       Date:  1981-01-31       Impact factor: 79.321

View more
  87 in total

Review 1.  'Overlap' syndromes.

Authors:  R Cervera; M A Khamashta; G R Hughes
Journal:  Ann Rheum Dis       Date:  1990-11       Impact factor: 19.103

Review 2.  Rheumatology.

Authors:  R A Asherson; R Cervera; D P D'Cruz; G R Hughes
Journal:  Postgrad Med J       Date:  1991-02       Impact factor: 2.401

3.  Occlusive ocular vascular disease and antiphospholipid antibodies.

Authors:  C Tolosa-Vilella; J Ordi-Ros; R Jordana-Comajuncosa; A Selva-O'Callaghan; M Vilardell-Tarres
Journal:  Ann Rheum Dis       Date:  1990-03       Impact factor: 19.103

4.  Isotype distribution of anticardiolipin antibodies in systemic lupus erythematosus: prospective analysis of a series of 100 patients.

Authors:  R Cervera; J Font; A López-Soto; F Casals; L Pallarés; A Bové; M Ingelmo; A Urbano-Márquez
Journal:  Ann Rheum Dis       Date:  1990-02       Impact factor: 19.103

5.  Prevalence of anticardiolipin antibodies in the elderly British population.

Authors:  K K Chakravarty; R E Gray; M Webley; M A Byron; J Wozniak
Journal:  Postgrad Med J       Date:  1991-04       Impact factor: 2.401

6.  Anti-Klebsiella K30 phospholipid antibodies in systemic lupus erythematosus: antigen cross-reactions and idiotypic sharing with antibodies to DNA and Klebsiella K30 polysaccharide.

Authors:  G D Harkiss; F M Hendrie; D Thompson
Journal:  J Clin Immunol       Date:  1988-07       Impact factor: 8.317

7.  Antiphospholipid antibodies and cerebral artery dissection: two frequent causes of brain ischemia in young adults.

Authors:  F Girmenia; C Argentino; E Di Scipio; F Orzi; C Pozzilli; M Rasura; J Faroni; G Valesini; C Fieschi
Journal:  Ital J Neurol Sci       Date:  1994-06

8.  Fetal loss treatment in patients with antiphospholipid antibodies.

Authors:  J Ordi; J Barquinero; M Vilardell; R Jordana; C Tolosa; A Selva; E Genover
Journal:  Ann Rheum Dis       Date:  1989-10       Impact factor: 19.103

Review 9.  The journey of antiphospholipid antibodies from cellular activation to antiphospholipid syndrome.

Authors:  Rohan Willis; E B Gonzalez; A R Brasier
Journal:  Curr Rheumatol Rep       Date:  2015-03       Impact factor: 4.592

10.  Calorie restriction prevents the occlusive coronary vascular disease of autoimmune (NZW x BXSB)F1 mice.

Authors:  H Mizutani; R W Engelman; K Kinjoh; Y Kurata; S Ikehara; Y Matsuzawa; R A Good
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.